13Q DELETION MM (CLL) / HEPARIN BLOOD

image not found

NABL Cap Accredited 
The 13q Deletion MM (CLL) Test using heparinized blood at Metropolis Healthcare detects the deletion of the 13q region in patients with chronic lymphocytic leukemia (CLL) or multiple myeloma (MM). This chromosomal abnormality helps assess disease prognosis and progression. Identifying 13q deletion is important for guiding personalized treatment strategies. The test provides insights into the patient’s risk profile and therapy response. It supports informed clinical decisions and monitoring of hematologic disorders.

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 5,195.00

Sample Type: HEPARIN BLOOD

Fasting Not Required


Booking Procedure:
  1. Technician from Metropolis will be assigned for a free home sample collection after booking confirmation.
  2. Sample will be collected by our technician at your address at given slot.
  3. You will get a payment link in 2 hours. You can make the payment online or pay cash to the technician.
  4. Soft copy reports will be sent to your email address within 24 to 48 hours.

Frequently Asked Questions (FAQ's):

 

1. What is the 13q Deletion MM (CLL) Test using heparinized blood?
This test detects the deletion of the 13q region in patients with CLL or multiple myeloma using a heparin-treated blood sample for accurate analysis.

2. Why is this test important?
It helps predict disease progression, assess prognosis, and guide personalized treatment plans in patients with CLL or MM.

3. Who should undergo this test?
Patients diagnosed with or suspected of having CLL, MM, or other hematologic disorders may be advised to take this test.

4. How is the test performed?
At Metropolis Healthcare, a heparinized blood sample is collected and analyzed using advanced cytogenetic and molecular techniques for precise detection.

5. What do the results indicate?
Detection of 13q deletion provides information about disease severity, prognosis, and treatment response, while absence indicates other genetic variants.

6. Are there any risks associated with the test?
The test is safe, with minimal risk related to blood sample collection.

7. Why choose Metropolis Healthcare for this test?
Metropolis Healthcare provides reliable genetic testing with advanced technology and expert analysis, ensuring accurate results for effective management of CLL and MM.

 

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab